Cortex, Boston Scientific

Boston Scientific to bolster cardiac ablation portfolio with Cortex acquisition
Boston Scientific has signed a definitive agreement for the acquisition of an Ajax Health company, Cortex, to bolster its cardiac ablation portfolio. The companies did not disclose the financial terms of the deal.
Boston Scientific continues M&A run with Cortex buy
Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ablation devices.
Boston Scientific to acquire Cortex, terms undisclosed
Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Cortex, Inc., an Ajax Health company. Cortex is a
Boston Scientific to Buy Medical-Technology Company Cortex
Boston Scientific has agreed to buy privately held medical- technology company Cortex from medical-device investor Ajax Health in a deal that bolsters its electrophysiology portfolio. Boston Scientific on Monday said it will pay an undisclosed amount for Cortex,
Boston Scientific to acquire AFib ablation tech firm Cortex
Boston Scientific (NYSE:BSX) has agreed to acquire privately held medical technology company, Cortex, Inc. Financial terms of the deal were not disclosed. The transaction is expected to close in the first half of 2025 and have an immaterial impact on adjusted earnings per share in 2025 and be slightly dilutive on a GAAP basis due to amortization expense and acquisition-related net charges.
Boston Scientific To Acquire Medical Technology Company Cortex; Terms Not Known
Monday said it has agreed to acquire medical technology company Cortex, Inc. Financial terms of the deal have not been disclosed. Cortex's OptiMap, a diagnostic mapping solution, helps physicians to identify triggers outside of the pulmonary veins that are foundational to atrial fibrillation (AF),
Boston Scientific Corp. stock rises Tuesday, still underperforms market
Shares of Boston Scientific Corp. BSX inched 0.97% higher to $85.54 Tuesday, on what proved to be an all-around positive ...
Axonics' Market Growth Strengthens Boston Scientific's Future
Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...
Boston Scientific (BSX): A Promising Medical Stock with Strong Revenue Growth
We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...
WBJournal1d
Boston Scientific to acquire California firm treating irregular heartbeats
Expanding its portfolio further into cardiovascular health, Marlborough medical device manufacturer Boston Scientific has ...
Why The Fundamentals Make Me Bullish On Boston Scientific
Boston Scientific's strong history, margins, and pipeline make it a buy despite other analysts' Hold rating, with 15% growth ...
FierceBiotech8d
In conversation with Boston Scientific's global medical chief, Ken Stein, taking the pulse of pulsed field ablation
Since rolling out its pulsed field ablation system for treating atrial fibrillation earlier this year, Boston Scientific has ...
Boston Scientific’s Acurate Neo2 inferior to rival TAVR valves in study
Analysts said the findings complicate the outlook for a U.S. launch of Boston Scientific's aortic valve replacement device.
Why is Boston Scientific Stock Trading Lower On Wednesday?
On Wednesday, Boston Scientific Corporation (NYSE:BSX) released the results of the primary endpoint of the ACURATE IDE trial ...
MassDevice7d
Boston Scientific Acurate neo2 TAVR misses primary endpoint in IDE trial
Boston Scientific (NYSE:BSX) today announced that a study of its Acurate neo2 aortic valve system missed its primary endpoint ...
Boston Scientific (BSX) Gets a Hold from Needham
In a report released today, Michael Matson from Needham maintained a Hold rating on Boston Scientific (BSX – Research Report). The ...